Fulcrum Therapeutics (FULC) Other Non-Current Assets (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Other Non-Current Assets data on file, last reported at $1.2 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $1.2 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (changed 0.0% YoY), and the FY2025 annual result was $1.2 million, up 11910.0% from the prior year.
• Other Non-Current Assets was little changed at $1.2 million in Q1 2026 per FULC's latest filing, from $1.2 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $2.1 million in Q4 2022 and troughed at $9000.0 in Q3 2025.
• A 5-year average of $1.1 million and a median of $1.2 million in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets tumbled 99.5% in 2024, then soared 11910.0% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $2.1 million in 2022, then slipped by 4.47% to $2.0 million in 2023, then plunged by 99.5% to $10000.0 in 2024, then soared by 11910.0% to $1.2 million in 2025, then changed by 0.0% to $1.2 million in 2026.
• Business Quant data shows FULC's Other Non-Current Assets at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $9000.0 in Q3 2025.